trending Market Intelligence /marketintelligence/en/news-insights/trending/rhcmply1hbsiqi2aje3mwg2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

G Medical plans Hong Kong IPO of Chinese unit

Blog

Global M&A Infographic Q1 2021

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

Blog

COVID-19 Impact & Recovery: Private Equity

COVID-19 Impact & Recovery: Corporates


G Medical plans Hong Kong IPO of Chinese unit

G Medical Innovations Holdings Ltd. is planning an IPO of its Chinese unit on the Hong Kong Stock Exchange.

The company is listing Guangzhou Yimei Innovative Medical Science and Technology Co. Ltd., or GYIMSTC Ltd., on the main board of the stock exchange. G Medical owns 70% of the unit.

Under the proposed listing, GYIMSTC will be spun off from G Medical, with the parent retaining not less than 50% ownership of the spunoff company.

G Medical, which designs smartphone apps to monitor health vitals, has hired UOB Kay Hian (Hong Kong) Ltd. to be the financial adviser for the IPO. The company and UOB are aiming toward a listing within six to nine months.

The initial market capitalization of GYIMSTC should be at least HK$1.50 billion under Hong Kong Stock Exchange rules.

Proceeds from the listing will be used for working capital and research and development.

The proposed listing is subject to legal and regulatory requirements in Australia and Hong Kong, including shareholder approval.